Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0623955A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCB SA
Original Assignee
UCB SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UCB SAfiledCriticalUCB SA
Priority to GB0623955ApriorityCriticalpatent/GB0623955D0/en
Publication of GB0623955D0publicationCriticalpatent/GB0623955D0/en
Priority to EP07846789Aprioritypatent/EP2099805A2/en
Priority to US12/515,380prioritypatent/US20100179185A1/en
Priority to PCT/EP2007/010189prioritypatent/WO2008064829A2/en
GB0623955A2006-11-302006-11-30Novel aminothienopyridinone derivatives processes for preparing them and pharmaceutical compositions thereof
CeasedGB0623955D0
(en)
2,3-dihydro-pyrido-1,4-oxazine and 2,3-dihydro-4-oxa-1,9-diazaphenanthrene derivatives, processes for their preparation and pharmaceutical compositions comprising them
N-substituted 1,4-androstadiene 3-oxo-6,9-dihalo-16-isoxazolidine-17-acyl derivatives, processes for their preparation, pharmaceutical compositions comprising them and uses thereof
Novel pyridinylaminoalkylene- and pyridinyloxyalkylene-cyclopropanamines, process for the preparation thereof and pharmaceutical compositions containing them